COVID-19 Information & Updates

COVID-19 Coverage and Billing - Public Health Emergency Set to End

As previously announced, our COVID-19 billing rules and guidelines will remain in effect through the Public Health Emergency (PHE), which expired on Thursday, May 11, 2023. As a result, some of the rules and guidelines put into place in response to the PHE will now be reversed. This means that member cost share and benefit plan rules may apply to services that were previously covered at 100% during the PHE.

Commercial and Medicare Advantage Post PHE Vaccination and Testing Coverage:

  • COVID-19 Vaccination and Administration - Will continue to be covered as a preventative health benefit with no member cost share.
  • COVID-19 Lab Tests - Will be covered, but subject to member cost share.
  • OTC COVID-19 Tests - Will only be covered for our Federal Employee Health Benefits (FEHB) members.

If you have questions about your coverage and COVID-19 and telehealth related costs, please call member services using the numbers below:

Commercial: 866.895.5828

Medicare Advantage: 800.455.9776

Latest on COVID-19: Testing & Vaccines

IU Health has a COVID-19 Resource Center with the latest information on testing, vaccines and more at iuhealth.org/covid19.

Security Information (TMG Health)

Updated August 9, 2023

For IU Health Medicare Advantage only: IU Health Plans reports notice of MOVEit data security incident involving its vendor, TMG Health.

IU Health Plans announced today that its claims processing vendor, TMG Health, Inc. (TMG), discovered a security incident involving TMG’s use of a third-party service, MOVEit Transfer, which recently reported a security vulnerability.

It is noteworthy that IU Health Plans is among more than 500 companies affected by the MOVEit security incident. In response to this situation, we want to assure all our members that safeguarding data privacy remains our top priority.

This security incident impacted IU Health Plans Medicare Advantage members only. Other IU Health Plans products lines (including IU Health Plans fully insured commercial products and the IU Health Team Member Plan) were not impacted.

On June 22, 2023, IU Health Plans was notified of the security incident by TMG who immediately initiated an investigation confirming downloads had been made by an unauthorized party between May 30, 2023 and June 2, 2023. The downloaded data included IU Health Plans Medicare Advantage member names, member identification numbers, and effective dates of plans, and in limited circumstances, banking account and routing numbers.

IU Health Plans began notifying affected Medicare Advantage members on Aug. 4, 2023. All IU Health Plans Medicare Advantage members impacted are being provided free credit monitoring by TMG. Additionally, TMG deployed the requisite security measures to ensure its systems are updated to block these activities from occurring in the future.

Moving forward

In the dynamic field of digital advancements, the challenge of preventing unauthorized access to data is an ongoing and pressing concern for all healthcare organizations, and IU Health Plans is no exception. IU Health Plans has taken steps to collaborate closely with our vendor, TMG. Together, we are strengthening our systems to prevent unauthorized activities, and continuing to set up strong defenses to stop any potential breaches in the future.

Since June 2, 2023, there has been no observed unauthorized activity, signifying a successful containment of the breach.

If you have any questions, please call toll-free 1-888-727-2311 or visit the TMG website at https://response.idx.us/notice-info. A list of frequently asked questions is also available online at https://response.idx.us/notice-info.

IU Health posted a notice about the incident on its website at: https://iuhealth.org/for-media/press-releases.

Security Information (EyeMed/Orrick)

August 31, 2023

IU Health Plans reports security incident by third-party vendor’s law firm

IU Health Plans announced today that the law firm of its network vision manager, EyeMed, recently experienced a security incident. The law firm, Orrick, Herrington & Sutcliffe, LLC (Orrick), served as legal counsel to EyeMed during its 2020 security event.

In relation to this representation, Orrick detected that an unauthorized third party gained access to a portion of its network between February 28 and March 13, 2023, including a file used to store certain client files of EyeMed containing IU Health Plan vision benefit plan members’ information. IU Health Plans first learned of this incident on June 29, 2023, and promptly initiated a review at that time.

Orrick immediately took steps to block the unauthorized access and initiated its response process, including launching an investigation of the incident with the support of a third-party forensics firm. Orrick also notified law enforcement. In addition to these actions, Orrick deployed additional security measures and tools with the guidance of third-party experts to strengthen the ongoing security of its network.

IU Health Plans began notifying affected members on August 31, 2023. The information affected by the Orrick security incident may have included: member name, address, date of birth, phone number, email address, vision insurance account/ID number, health insurance account/ID number, health insurance account/ID number, and full or partial Social Security numbers. IU Health Plans wants to ensure that its information is protected, and Orrick will be offering free credit monitoring to those IU Health Plans members impacted.

If you have any questions, please call toll-free at 866-347-7897, Monday through Friday from 9:00 am to 6:30 pm Eastern Time, excluding major U.S. holidays. Callers who are deaf, hard-of-hearing, or speech-disabled may utilize their TeleTYpewriter (TTY) or Telecommunication Device (TDD) to access an operator at 866-347-7897, Monday through Friday, from 9:00 am to 6:30 pm Eastern Time, excluding major U.S. holidays.

COVID-19 Information & Updates

Security Information (TMG Health)

Security Information (EyeMed/Orrick)

COVID-19 Coverage and Billing - Public Health Emergency Set to End

As previously announced, our COVID-19 billing rules and guidelines will remain in effect through the Public Health Emergency (PHE), which expired on Thursday, May 11, 2023. As a result, some of the rules and guidelines put into place in response to the PHE will now be reversed. This means that member cost share and benefit plan rules may apply to services that were previously covered at 100% during the PHE.

Commercial and Medicare Advantage Post PHE Vaccination and Testing Coverage:

  • COVID-19 Vaccination and Administration - Will continue to be covered as a preventative health benefit with no member cost share.
  • COVID-19 Lab Tests - Will be covered, but subject to member cost share.
  • OTC COVID-19 Tests - Will only be covered for our Federal Employee Health Benefits (FEHB) members.

If you have questions about your coverage and COVID-19 and telehealth related costs, please call member services using the numbers below:

Commercial: 866.895.5828

Medicare Advantage: 800.455.9776

Latest on COVID-19: Testing & Vaccines

IU Health has a COVID-19 Resource Center with the latest information on testing, vaccines and more at iuhealth.org/covid19.

Updated August 9, 2023

For IU Health Medicare Advantage only: IU Health Plans reports notice of MOVEit data security incident involving its vendor, TMG Health.

IU Health Plans announced today that its claims processing vendor, TMG Health, Inc. (TMG), discovered a security incident involving TMG’s use of a third-party service, MOVEit Transfer, which recently reported a security vulnerability.

It is noteworthy that IU Health Plans is among more than 500 companies affected by the MOVEit security incident. In response to this situation, we want to assure all our members that safeguarding data privacy remains our top priority.

This security incident impacted IU Health Plans Medicare Advantage members only. Other IU Health Plans products lines (including IU Health Plans fully insured commercial products and the IU Health Team Member Plan) were not impacted.

On June 22, 2023, IU Health Plans was notified of the security incident by TMG who immediately initiated an investigation confirming downloads had been made by an unauthorized party between May 30, 2023 and June 2, 2023. The downloaded data included IU Health Plans Medicare Advantage member names, member identification numbers, and effective dates of plans, and in limited circumstances, banking account and routing numbers.

IU Health Plans began notifying affected Medicare Advantage members on Aug. 4, 2023. All IU Health Plans Medicare Advantage members impacted are being provided free credit monitoring by TMG. Additionally, TMG deployed the requisite security measures to ensure its systems are updated to block these activities from occurring in the future.

Moving forward

In the dynamic field of digital advancements, the challenge of preventing unauthorized access to data is an ongoing and pressing concern for all healthcare organizations, and IU Health Plans is no exception. IU Health Plans has taken steps to collaborate closely with our vendor, TMG. Together, we are strengthening our systems to prevent unauthorized activities, and continuing to set up strong defenses to stop any potential breaches in the future.

Since June 2, 2023, there has been no observed unauthorized activity, signifying a successful containment of the breach.

If you have any questions, please call toll-free 1-888-727-2311 or visit the TMG website at https://response.idx.us/notice-info. A list of frequently asked questions is also available online at https://response.idx.us/notice-info.

IU Health posted a notice about the incident on its website at: https://iuhealth.org/for-media/press-releases.

August 31, 2023

IU Health Plans reports security incident by third-party vendor’s law firm

IU Health Plans announced today that the law firm of its network vision manager, EyeMed, recently experienced a security incident. The law firm, Orrick, Herrington & Sutcliffe, LLC (Orrick), served as legal counsel to EyeMed during its 2020 security event.

In relation to this representation, Orrick detected that an unauthorized third party gained access to a portion of its network between February 28 and March 13, 2023, including a file used to store certain client files of EyeMed containing IU Health Plan vision benefit plan members’ information. IU Health Plans first learned of this incident on June 29, 2023, and promptly initiated a review at that time.

Orrick immediately took steps to block the unauthorized access and initiated its response process, including launching an investigation of the incident with the support of a third-party forensics firm. Orrick also notified law enforcement. In addition to these actions, Orrick deployed additional security measures and tools with the guidance of third-party experts to strengthen the ongoing security of its network.

IU Health Plans began notifying affected members on August 31, 2023. The information affected by the Orrick security incident may have included: member name, address, date of birth, phone number, email address, vision insurance account/ID number, health insurance account/ID number, health insurance account/ID number, and full or partial Social Security numbers. IU Health Plans wants to ensure that its information is protected, and Orrick will be offering free credit monitoring to those IU Health Plans members impacted.

If you have any questions, please call toll-free at 866-347-7897, Monday through Friday from 9:00 am to 6:30 pm Eastern Time, excluding major U.S. holidays. Callers who are deaf, hard-of-hearing, or speech-disabled may utilize their TeleTYpewriter (TTY) or Telecommunication Device (TDD) to access an operator at 866-347-7897, Monday through Friday, from 9:00 am to 6:30 pm Eastern Time, excluding major U.S. holidays.

Search

Drug Safety Withdrawals & Recalls

In the interest of our members’ health and safety, IU Health Plans monitors alerts from the Food and Drug Administration (FDA) regarding prescription drug recalls and withdrawals. Drugs may be recalled by the FDA or withdrawn from the market by a manufacturer for a variety of reasons including safety and efficacy. IU Health Plans identifies and notifies members that may be potentially impacted when a prescription drug is recalled or withdrawn. In addition to these notifications, updates will be provided on this webpage for easy access for our members and providers.

The FDA classifies recalls according to the potential consequences the drug may cause. The FDA defines these classifications as follows:

Class I: Dangerous or defective products (including drugs) that predictably could cause serious health problems or death. Examples include: a label mix-up on a lifesaving drug

Class II: Products (including drugs) that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.

A drug manufacturer may call a voluntary market withdrawal to remove or correct a marketed drug that the FDA may consider to be in violation of FDA laws.

If you receive a notice that your medications may be impacted by a drug recall please act upon the notice and follow up with your prescriber and/or pharmacy as instructed. If you have additional questions about your prescription drug benefits please contact us.


Metoprolol 01.20.23

Allopurinol 01.20.23

Ferrous Sulfate 01.19.23

Rifampin 01.18.23

Multiple Akorn Inc. Products 01.14.23

Rifampin 01.09.23

Glycopyrrolate 12.22.22

Quinapril 12.21.22

Desmopressin 11.29.22

Arformoterol 09.30.22

Golden State MS 09.29.22

Rifampin 09.28.22

Neoral 09.26.22

Dextroamphetamine 09.16.22

Lisinopril 09.15.22

Difluprednate 09.07.22

Triamcinolone 09.07.22

Neomycin 08.30.22

Rifampin 08.16.22

Diltiazem Hydrochloride 08.04.22

Divalproex 07.26.22

Magnesium Citrate 07.25.22

Testosterone 07.25.22

Lansoprazole 07.23.22

Difluprednate 07.20.22

Eszopiclone 07.05.22

Calcipotriene 06.29.22

Tretinoin 06.23.22

Testosterone 06.22.22

Zileuton 06.16.22

Losartan 05.28.22

Anagrelide 06.20.22

Daytrana 05.20.22

Losartan 05.03.22

Lansoprazole 05.05.22

Pantoprazole Sodium 05.05.22

Alprazolam ER 05.03.22

Lansoprazole DR 03.31.22

Orphenadrine Citrate ER 03.23.22

Accuretic and quinapril 03.21.22

Lidocaine 2.5 % and Prilocaine 2.5 % Cream 04.28.22

Glenmark Pharmaceuticals 04.25.22 

Accupril 04.22.22 

Teligent Pharmaceuticals 03.21.22

Similac®, Alimentum®, and EleCare® 02.18.22 & 02.28.22

Polymyxin 1.26.22

Octagam 01.22.22

Metformin 01.07.22

Hizentra 12.30.21 

Clobetasol 12.30.21 

Nitroglycerin 12.27.21

Hizentra 10.27.21 

Lidocaine 10.12.21 

Enoxaparin 12.02.21

Irbesartan 10.12.21

Glucagon 09.25.21

Lidocaine 08.27.21 

Monojet 08.27.21

Atovaquone 08.06.21

Xolair 06.09.21 

Gamunex 04.27.21

Thyroid 04.29.21 

Hizentra 04.13.21

Guanfacine 03.31.21 

Spironolactone 01.27.21 

Enoxaparin 02.03.21 

Ketorolac 02.03.21 

Metformin 01.04.21 

Chlorhexidine 12.28.20 

Anagrelide 12.09.20 

Sildenafil & Trazodone 12.08.20 

Metformin 11.02.20

Chlorhexidine 10.28.20